Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Cyclobenzaprine (brand name Flexeril) is a prescription muscle relaxant used short term to ease muscle spasms, stiffness, and pain from acute strains, sprains, and back or neck injuries, typically alongside rest and physical therapy. It is usually prescribed for no more than two to three weeks, because most of its benefit shows up in the first few days and its safety and effectiveness beyond that window have not been established, while side effects
Cyclobenzaprine is a prescription muscle relaxant prescribed to help relieve muscle spasms and discomfort. It’s chemically related to certain antidepressants but is mainly used for short-term relief of acute musculoskeletal conditions. Cyclobenzaprine works by acting on the central nervous system to reduce the transmission of pain signals and ease muscle tightness.
Understanding “cyclobenzaprine uses” will help you and your doctor decide if it’s right for you. Common approved uses include:
Off-label uses (those not specifically approved by regulatory agencies but sometimes prescribed) may include:
Always speak with your doctor before using cyclobenzaprine for any off-label purpose.
Cyclobenzaprine acts centrally—meaning it works in your brain and spinal cord, not directly on the muscles. It:
Because it affects the central nervous system, common side effects include drowsiness and dizziness. These effects tend to be more pronounced when you first start taking it or after a dosage increase.
Typical dosing guidelines for adults:
Key points:
Children under 15 years of age generally are not prescribed cyclobenzaprine due to lack of safety data.
Cyclobenzaprine is intended for short-term use only. Clinical studies and expert guidelines recommend:
Why short duration?
If you feel your muscle spasms aren’t improving after 2–3 weeks, talk to your doctor about alternative treatments such as physical therapy, other medications, or lifestyle adjustments.
Before taking cyclobenzaprine, let your doctor know if you have:
Avoid alcohol and other sedatives (e.g., benzodiazepines, opioids) while taking cyclobenzaprine, as combining these can increase drowsiness and risk of respiratory depression.
Most people tolerate cyclobenzaprine well when used as directed. Side effects may include:
If side effects are mild, they often improve within a few days. To help manage them:
Although rare, serious reactions can occur. Contact a doctor immediately if you experience:
If you suspect a life-threatening or serious problem, seek emergency care right away.
Cyclobenzaprine can interact with other medications, increasing side effects or reducing effectiveness:
Always give your healthcare provider a full list of all prescription drugs, over-the-counter medicines, and herbal supplements you’re taking.
If you’re taking cyclobenzaprine and notice:
…contact your healthcare provider. They may adjust your dose, switch medications, or recommend non-drug therapies.
Wondering if cyclobenzaprine is right for your muscle pain and spasms? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to learn more about your condition and potential treatment options.
After any self-assessment or online tool:
This overview of cyclobenzaprine uses and safe duration of treatment is for informational purposes and does not replace medical advice. Always:
Your doctor can tailor treatment to your health history, symptom severity, and overall wellness goals.
(References)
* Gatter RA. Pharmacotherapeutics in fibrositis. Am J Med. 1986 Sep 29;81(3A):63-6. doi: 10.1016/0002-9343(86)90878-8. PMID: 3464210.
* Linden CH, Mitchiner JC, Lindzon RD, Rumack BH. Cyclobenzaprine overdosage. J Toxicol Clin Toxicol. 1983 May;20(3):281-8. doi: 10.3109/15563658308990071. PMID: 6620442.
* See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008 Feb;28(2):207-13. doi: 10.1592/phco.28.2.207. PMID: 18225966.
* Reuss R, Reuter I, Jauss M, Fischer F, Muller SC, Stolz E. Torticollis under cyclobenzaprine. Pharmacology. 2009;84(2):91-2. doi: 10.1159/000227773. Epub 2009 Jul 8. PMID: 19590258.
* Dey S, Kopitnik NL, Vrooman BM. Alternatives to Opioids for Managing Pain. 2024 Jan. PMID: 34662057.
* Martinez JE, Guimarães I. "Fibromyalgia - are there any new approaches?". Best Pract Res Clin Rheumatol. 2024 Mar;38(1):101933. doi: 10.1016/j.berh.2024.101933. Epub 2024 Feb 13. PMID: 38355316.
* Oldfield BJ, Gleeson B, Morford KL, Adams Z, Funaro MC, Becker WC, Merlin JS. Long-Term Use of Muscle Relaxant Medications for Chronic Pain: A Systematic Review. JAMA Netw Open. 2024 Sep 3;7(9):e2434835. doi: 10.1001/jamanetworkopen.2024.34835. Epub 2024 Sep 3. PMID: 39298168; PMCID: PMC11413720.
* Lederman S, Arnold LM, Vaughn B, Engels JM, Kelley M, Sullivan GM. Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine. Pain Med. 2026 Jan 1;27(1):86-94. doi: 10.1093/pm/pnaf089. PMID: 40627411; PMCID: PMC12773742.
* Cua A, Wickett E, Pesce AJ. Urinary metabolic ratio of pain management and substance abuse treatment drugs: Drug-drug interactions. J Opioid Manag. 2025 Special Supplement: Data and Analysis of Apr Million Drug Samples;21(7):41-68. doi: 10.5055/jom.0907. PMID: 40738618.
* Cashin AG, Chou R, Weimer MB, McAuley JH. Low Back Pain: A Review. JAMA. 2026 Jul 14;336(2):144-158. doi: 10.1001/jama.2026.9631. PMID: 42295944.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.